Blog

  • Jim Fitzpatrick – 2016 Parliamentary Question to the Department of Health

    Jim Fitzpatrick – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Fitzpatrick on 2016-05-25.

    To ask the Secretary of State for Health, what assessment he has made of the National Screening Committee’s recommendations for the bowel and cervical screening programmes; and whether he plans to support those recommendations

    Jane Ellison

    Ministers have accepted the UK National Screening Committee’s (UK NSC) recommendation on replacing the guaiac Faecal Occult Blood test with the Faecal Immunochemical Test (FIT) in the NHS Bowel Cancer Screening Programme. Following the change to FIT we expect that around 200,000 more people per year will take up the opportunity to be screened as part of the NHS Bowel Cancer Screening Programme in England. This has the potential to save hundreds more lives by detecting bowel cancer earlier. Public Health England is responsible for the leadership of the NHS Screening Programmes and will oversee the change to the programme in partnership with NHS England.

    Ministers are currently considering the UK NSC’s recommendation that human papillomavirus testing should replace the currently used cytology test as primary screening for cervical disease.

  • Jim Fitzpatrick – 2016 Parliamentary Question to the Department of Health

    Jim Fitzpatrick – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Fitzpatrick on 2016-05-25.

    To ask the Secretary of State for Health, when his Department plans to implement the National Screening Committee’s recommendations on introducing (a) the Faecal Immunochemical Test into the bowel screening programme and (b) HPV as the primary test in the cervical screening programme.

    Jane Ellison

    Ministers have accepted the UK National Screening Committee’s (UK NSC) recommendation on replacing the guaiac Faecal Occult Blood test with the Faecal Immunochemical Test (FIT) in the NHS Bowel Cancer Screening Programme. Following the change to FIT we expect that around 200,000 more people per year will take up the opportunity to be screened as part of the NHS Bowel Cancer Screening Programme in England. This has the potential to save hundreds more lives by detecting bowel cancer earlier. Public Health England is responsible for the leadership of the NHS Screening Programmes and will oversee the change to the programme in partnership with NHS England.

    Ministers are currently considering the UK NSC’s recommendation that human papillomavirus testing should replace the currently used cytology test as primary screening for cervical disease.

  • Andrew Gwynne – 2016 Parliamentary Question to the Department of Health

    Andrew Gwynne – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andrew Gwynne on 2016-05-25.

    To ask the Secretary of State for Health, what discussions his Department has had with NHS Supply Chain on that organisation’s decision on the choice of urine drainage bags available through the NHS Core List Programme.

    George Freeman

    The NHS Supply Chain Core List Programme was developed in collaboration with NHS Business Services Authority and the Department. The Core List aims to achieve best value by reducing the range of like-for-like products that the National Health Service purchases. This allows the NHS to commit to larger volumes of a smaller range of products which in turn allows suppliers to provide improved prices to the NHS as greater economies of scale in manufacturing can be achieved.

    Items identified as ‘Core List’ have been reviewed and assessed by a selection of industry specialists, clinical advisors and customers. Products not included in the NHS Core List are not discontinued and are therefore still available for purchase via the wider NHS catalogue offered by NHS Supply Chain.

    Ultimately, decisions with regard to which urine drainage bag to purchase lies with the procurement team for each individual NHS trust.

  • Andrea Jenkyns – 2016 Parliamentary Question to the Department of Health

    Andrea Jenkyns – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andrea Jenkyns on 2016-05-25.

    To ask the Secretary of State for Health, with reference to page 23 of the final report of the Review on Antimicrobial Resistance, published in May 2016, what steps his Department is taking to address the substantial evidence gaps relating to effectiveness and cost-effectiveness of new technologies for improving hygiene.

    Ben Gummer

    Auditing to improve hand hygiene and ensuring appropriate use of technology are important local responsibilities which contribute to improving the quality of care. However, tackling healthcare associated infections is complex and requires a strong patient safety system that integrates cleanliness, infection prevention and control and antibiotic use and addresses them all.

    To help the National Health Service improve infection prevention and control we continuously review and enhance national measures, systems and guidance. For example, reducing infections is part of the Guidance for the NHS on Sustainability and Transformation Plans. Antimicrobial resistance was added to Public Health England’s (PHE) Fingertips data system in April to enable easier monitoring and benchmarking against other organisations. PHE’s Rapid Review Panel assesses new products and technologies aiming to reduce infections and in addition the Department’s National Institute for Health Research (NIHR) welcomes funding applications for research into any aspect of human health, including hygiene.

    The NIHR also supports research infrastructure in the NHS including Diagnostic Evidence Co-operatives which generate evidence on diagnostic medical devices that have the potential to lead to improvements in healthcare services and the quality of life of NHS patients. Two of these, based at Imperial and Newcastle, focus part of their work on clinical areas relevant to infection.

  • Andrea Jenkyns – 2016 Parliamentary Question to the Department of Health

    Andrea Jenkyns – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andrea Jenkyns on 2016-05-25.

    To ask the Secretary of State for Health, with reference to page 23 of the final report of the Review on Antimicrobial Resistance, published in May 2016, what steps his Department is taking to address the low level of adherence to proper hand hygiene in hospitals and other care settings.

    Ben Gummer

    Auditing to improve hand hygiene and ensuring appropriate use of technology are important local responsibilities which contribute to improving the quality of care. However, tackling healthcare associated infections is complex and requires a strong patient safety system that integrates cleanliness, infection prevention and control and antibiotic use and addresses them all.

    To help the National Health Service improve infection prevention and control we continuously review and enhance national measures, systems and guidance. For example, reducing infections is part of the Guidance for the NHS on Sustainability and Transformation Plans. Antimicrobial resistance was added to Public Health England’s (PHE) Fingertips data system in April to enable easier monitoring and benchmarking against other organisations. PHE’s Rapid Review Panel assesses new products and technologies aiming to reduce infections and in addition the Department’s National Institute for Health Research (NIHR) welcomes funding applications for research into any aspect of human health, including hygiene.

    The NIHR also supports research infrastructure in the NHS including Diagnostic Evidence Co-operatives which generate evidence on diagnostic medical devices that have the potential to lead to improvements in healthcare services and the quality of life of NHS patients. Two of these, based at Imperial and Newcastle, focus part of their work on clinical areas relevant to infection.

  • Nicholas Soames – 2016 Parliamentary Question to the Department of Health

    Nicholas Soames – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Nicholas Soames on 2016-05-25.

    To ask the Secretary of State for Health, what steps he plans to take to expand health services in Mid Sussex to meet increased housing and population numbers.

    Alistair Burt

    NHS England has advised that the Horsham and Mid Sussex Clinical Commissioning Group (CCG) is using the predicted population data from the developing estates strategy to model health services to meet the increased demand. NHS England further advises that it is working closely with the CCG to develop an action plan for local primary care services in East Grinstead.

    NHS England is responsible for commissioning of primary care in Mid Sussex. NHS England advises that only one general practitioner practice in Grinstead has closed its list to new patients and two others have applied to close their lists but are still currently being allocated patients by NHS England.

  • Nicholas Soames – 2016 Parliamentary Question to the Department of Health

    Nicholas Soames – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Nicholas Soames on 2016-05-25.

    To ask the Secretary of State for Health, for what reasons GP practice lists have been closed in East Grinstead; and if he will make a statement.

    Alistair Burt

    NHS England has advised that the Horsham and Mid Sussex Clinical Commissioning Group (CCG) is using the predicted population data from the developing estates strategy to model health services to meet the increased demand. NHS England further advises that it is working closely with the CCG to develop an action plan for local primary care services in East Grinstead.

    NHS England is responsible for commissioning of primary care in Mid Sussex. NHS England advises that only one general practitioner practice in Grinstead has closed its list to new patients and two others have applied to close their lists but are still currently being allocated patients by NHS England.

  • Catherine McKinnell – 2016 Parliamentary Question to the Department of Health

    Catherine McKinnell – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Catherine McKinnell on 2016-05-25.

    To ask the Secretary of State for Health, with reference to the Answer of 2 March 2016 to Question 29364, what the grounds are for the Public Health England Office for Data Release denying requests made to it for information collected via the Systemic Anti-Cancer Therapy dataset; what the timescale is for that office to respond to any requests made; and whether there will be a public announcement setting out the date when requests for data may be made to that office.

    George Freeman

    Public Health England (PHE) is making data collected as part of the Systemic Anti-Cancer Therapy dataset available through its Office for Data Release (ODR) function. The data have been available since April 2016 and the ODR is currently processing requests. The priority of PHE, and the ODR, is to maintain patient confidentiality and therefore data will only be released to external parties in a format that does not compromise patient confidentiality either directly or by inference.

  • Mike Kane – 2016 Parliamentary Question to the Department of Health

    Mike Kane – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Mike Kane on 2016-05-25.

    To ask the Secretary of State for Health, whether healthcare professionals in Greater Manchester expressed support for the introduction of charging for (a) primary care and (b) emergency care in response to his Department’s consultation, Making a fair contribution: consultation on the extension of charging overseas visitors and migrants using the NHS in England.

    Alistair Burt

    The Government is currently analysing responses to this consultation and will publish its response in due course.

  • Colleen Fletcher – 2016 Parliamentary Question to the Department of Health

    Colleen Fletcher – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Colleen Fletcher on 2016-05-25.

    To ask the Secretary of State for Health, what assessment he has made of the (a) efficiency of existing diagnostic tests and (b) effectiveness of current treatments for Lyme disease.

    Jane Ellison

    Lyme disease is a complex infection where challenges in understanding of disease progression, and consequently diagnosis and treatment, remain.

    The National Health Service and Public Health England (PHE) use well established validated diagnostic tests for Lyme disease that are highly reproducible between laboratories. International External Quality Assurance schemes are in place to ensure consistency between different test centres. Commercial manufacturers and international academic groups have research programmes into improved tests and PHE continuously reviews new Lyme serology tests and will validate and implement new tests if appropriate.

    All treatment for Lyme disease within the NHS should be evidence based, and targeted at the disease mechanisms underlying those symptoms. Most cases are diagnosed in primary care and PHE has published a referral pathway for general practitioners to follow to ensure problem cases are seen by an appropriate NHS specialist.

    To further strengthen the evidence base we have commissioned the National Institute for Health and Care Excellence to develop a new clinical guideline on Lyme disease, for both primary and secondary care, for publication in 2018. The Department is also commissioning three Systematic Reviews by independent academic groups to cover

    ― diagnosis and diagnostic tests;

    ― treatment; and

    ― epidemiology/transmission routes.